Îêóëèñò (îôòàëüìîëîã)
Ïðèåì îò 4000 3800 - 5%
Âðà÷ ïðèíèìàåò â ñëåäóþùèõ êëèíèêàõ:
Ñòîèìîñòü ïðè¸ìà â «Îôòàëüìîëîãè÷åñêàÿ êëèíèêà Ýêñèìåð (Íîâîñèáèðñê)»
Àäðåñ: Ôåäîñååâà ä. 2/1
Ìåòðî: Áåðåçîâàÿ Ðîùà Çîëîòàÿ Íèâà
Îáùèå ñâåäåíèÿ
Äèàãíîñòèêà è ëå÷åíèå ñëåäóþùèõ çàáîëåâàíèé:
- àñòèãìàòèçì;
- áëèçîðóêîñòü (ìèîïèÿ);
- äàëüíîçîðêîñòü (ãèïåðìåòðîïèÿ);
- êîíúþíêòèâèò (âèðóñíûé, áàêòåðèàëüíûé, àëëåðãè÷åñêèé);
- êîñîãëàçèå;
- ÿ÷ìåíü;
- êàòàðàêòà;
- ãëàóêîìà;
- äèàáåòè÷åñêàÿ ðåòèíîïàòèÿ;
- îòñëîåíèå ñåò÷àòêè ãëàçà;
- äèñòðîôèÿ ñåò÷àòêè;
- õàëÿçèîí;
- êîñîãëàçèå.
Îáðàçîâàíèå
- Äèïëîì ïî ñïåöèàëüíîñòè "Ëå÷åáíîå äåëî (Ëå÷åáíî-ïðîôèëàêòè÷åñêîå äåëî)", Íîâîñèáèðñêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò (2015 ã.)
- Îðäèíàòóðà ïî ñïåöèàëüíîñòè "Îôòàëüìîëîãèÿ", Ìåäèöèíñêèé óíèâåðñèòåò èííîâàöèé è ðàçâèòèÿ (2016 ã.)
Ïîâûøåíèå êâàëèôèêàöèè
- "Îêàçàíèå íåîòëîæíîé ïîìîùè", Ãîðîäñêàÿ Êëèíè÷åñêàÿ Áîëüíèöà ¹1 (2017 ã.)
- "Îñíîâû ïîäáîðà ÌÊË", Johnson & Johnson Institute, ã.Ìîñêâà (2019 ã.)
- "Îôòàëüìîëîãèÿ" (2020 ã.)
- "Ãëàçíûå ïðîÿâëåíèÿ íîâîé êîðîíàâèðóñíîé èíôåêöèè", Ñèáèðü. Íàóêà. Èíòåëëåêò (2021 ã.)
- "Îñíîâû ïîäáîðà òîðè÷åñêèõ ÌÊË", Johnson & Johnson Institute, ã.Ìîñêâà (2022 ã.)
- "Èíôåêöèè, ñâÿçàííûå ñ îêàçàíèåì ìåäèöèíñêîé ïîìîùè", Íîâîñèáèðñêèé èíñòèòóò ïîâûøåíèÿ êâàëèôèêàöèè ðàáîòíèêîâ çäðàâîîõðàíåíèÿ (2023 ã.)
- "Ìàñòåðñòâî ïîäáîðà òîðè÷åñêèõ ìÿãêèõ êîíòàêòíûõ ëèíç", Johnson & Johnson Institute, ã.Ìîñêâà (2024 ã.)
Ìåñòà ðàáîòû
- Îïòîìåòðèñò, âðà÷-îôòàëüìîëîã, Ñåòü îïòè÷åñêèõ ñàëîíîâ «ËèíçÌàñòåð», ãîðîä Íîâîñèáèðñê (2016-2017 ãã.)
- Âðà÷-îôòàëüìîëîã ïî îêàçàíèþ íåîòëîæíîé îôòàëüìîëîãè÷åñêîé ïîìîùè, ÃÁÓÇ ÍÑÎ ÃÊÁ ¹1, ãîðîä Íîâîñèáèðñê (2016-2018 ãã.)
- Âðà÷-îôòàëüìîëîã, ÎÎÎ Ôèðìà «TAMARA», ãîðîä Íîâîñèáèðñê (2017-2024 ãã.)